Biomedical Engineering Reference
In-Depth Information
Mewada A, Pandey S, Thakur M, Jadhav D, Sharon M (2014) Swarming carbon dots for folic
acid mediated delivery of doxorubicin and biological imaging. J Mater Chem B 2:698-705
Miao J, Du YZ, Yuan H, Zhang XG, Hu FQ (2013) Drug resistance reversal activity of antican-
cer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids Surf B
110:74-80
Min J, Moon H, Yang HJ, Shin HH, Hong SY, Kang S (2014) Development of P22 viral capsid
nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms. Macromol
Biosci 14:557-564
Minelli R, Serpe L, Pettazzoni P, Minero V, Barrera G, Gigliotti CL, Mesturini R, Rosa AC,
Gasco P, Vivenza N, Muntoni E, Fantozzi R, Dianzani U, Zara GP, Dianzani C (2012)
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon can-
cer cells. Br J Pharmacol 166:587-601
Mitra S, Chandra S, Pathan SH, Sikdar N, Pramanik P, Goswami A (2013) Room tempera-
ture and solvothermal green synthesis of self passivated carbon quantum dots. RSC Adv
3:3189-3193
Miyake Y, Kimura Y, Ishikawa S, Tsujita H, Miura H, Narazaki M, Matsuda T, Tabata Y, Yano
T, Toshimitsu A, Kondo T (2012) Synthesis and functional evaluation of chiral dendrimer—
triamine-coordinated Gd complexes as highly sensitive MRI contrast agents. Tetrahedron Lett
53:4580-4583
Mojahediana MM, Daneshamouzb S, Samanib SM, Zargaran A (2013) A novel method to
produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to
the o/w microemulsionquenching technique. Chem Phys Lipids 174:32-38
Moorthi C, Manavalan R, Kathiresan K (2011) Nanotherapeutics to overcome conventional
cancer chemotherapy limitations. J Pharm Pharm Sci 14:67-77
Morsi NM, Ghorab DM, Badie HA (2013) Brain targeted solid lipid nanoparticles for brain isch-
emia: preparation and in vitro characterization. Pharm Dev Technol 18:736-744
Most RG, Robinson BWS, Nelson DJ (2006) Gene therapy for malignant mesothelioma: beyond
the infant years. Cancer Gene Ther 13:897-904
Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR (2012) Apoptosis-induced
anticancer effect of transferrin conjugated solid lipid nanoparticles of curcumin. Cancer Nano
3:65-81
Mulika RS, Monkkonenc J, Juvonend RO, Mahadika KR, Paradkarb AR (2010) Transferrin
mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity
by induction of apoptosis. Int J Pharm 398:190-203
Mulla JS, Khazi IM, Sharma NK, Hiremath SP, Jamakandi VG (2011) Solid lipid nanoparticles:
methods of preparation. Indian J Novel Drug Deliv 3:170-175
Müller C, Struthers H, Winiger C, Zhernosekov K, Schibli R (2013) DOTA conjugate with an
albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy
in mice. J Nucl Med 54:124-131
Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug
delivery—a review of the state of the art. Eur J Pharm Biopharm 50:161-177
Murawala P, Tirmale A, Shiras A, Prasad BLV (2014) In situ synthesized BSA capped gold
nanoparticles: Effective carrier of anticancer drug MTX to MCF-7 breast cancer cells. Mater
Sci Eng C 34:158-167
Murugesan S, Shettyc SJ, Srivastava TS, Noronha OPD, Samuel AM (2001) A technetium-99
m-labelled cyclam acid porphyrin (CAP) for tumour imaging. Appl Radiat Isot 55:641-646
Mussi SV, Silva RC, Oliveira MC, Lucci CM, Azevedo RB, Ferreira LAM (2013) New approach
to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanopar-
ticles. Eur J Pharm Sci 48:282-290
Muthu MS, Kulkarni SA, Raju A, Feng SS (2012) Theranostic liposomes of TPGS coating for
targeted co-delivery of docetaxel and quantum dots. Biomaterials 33:3494-3501
Khlebtsov N, Dykman L (2011) Gold nanoparticles in biomedical applications: recent advances
and perspectives. Chem Soc Rev 40:1647-1671
